SlideShare a Scribd company logo
Applied Multivariable
  Modeling in Public Health
Use of CART® and Logistic Regression to
     Help Diagnose HIV Infection

                 Jason S. Haukoos, MD, MSc
          Associate Professor & Director of Research
             Department of Emergency Medicine
                Denver Health Medical Center
          University of Colorado School of Medicine
                Department of Epidemiology
              Colorado School of Public Health
                       Denver, Colorado

      Salford Analytics and Data Mining Conference 2012
                         May 25, 2012
Supported by an Independent Scientist
Award (K02 HS017526) from the Agency
 for Healthcare Research and Quality
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Awareness in the United States


Number with HIV infection         1,200,000


Number unaware of HIV infection    250,000

Annual new infections               56,000
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
HIV Epidemic in the U.S.
The numbers of people infected with HIV is growing
fastest among
   Racial and ethnic minorities
   Social and economically disadvantaged


These are the same groups that are
   Under- or uninsured
   Do not have primary medical care
   Commonly seek medical care in emergency departments
www.DenverEDHIV.org
Earlier Diagnosis of HIV Infection Benefits
          both Patient and Public
Benefits for the Patient
   Timely linkage to care
   Reduced morbidity and mortality due to HAART
   Reduced at-risk behavior


Benefits for the Public
   Earlier treatment, decreased viral load, decreased
   transmission
   Reduced unscheduled medical care and length of inpatient
   hospitalizations
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Strategies for Uncovering HIV
Figure 1. Conceptual model for performing HIV testing in emergency departments.


                                                                                             Nontargeted HIV
     No HIV
                                                                                                Screening
     Testing
                                                                                           (“Routine Screening”)
                    Diagnostic Testing       Traditional Targeted   Enhanced Targeted
                   (Signs or Symptoms)           Screening             Screening


                    Selection of                                            Selection of
                    Individuals                                             Populations

    Referral for
    outpatient                Operational Considerations for All Testing Models
    HIV testing
                                          Opt-in versus Opt-out Consent

                                           Education versus Counseling

                                         Rapid versus Conventional Assay

                             Point-of-Care Testing versus Laboratory-based Testing

                            Result Notification, Reporting, and Linkage of Positives

                                         Native versus External Resources

                                                       Rothman et al. Acad Emerg Med 2007;14:653-657.
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Haukoos. Arch Intern Med 2012;172:20-22.
Objective

     To systematically evaluate a large number of
 characteristics to derive a clinically meaningful and
valid prediction tool to accurately categorize patients
    into risk groups for undiagnosed HIV infection
Derivation Methods

Denver Metro Health STD Clinic, Denver, CO

10,000 annual visits & 0.5% HIV prevalence

Consecutive patients from 1/1/1996 – 12/31/2008
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Candidate Variables
Demographics           Hepatitis B                                Sexual Practices
 Age                   Hepatitis C                                 Vaginal sex
 Sex                  Previous HIV Testing                         Given oral sex
 Race/ethnicity        Ever tested                                 Received oral sex
Symptoms               Last tested                                 Given anal sex
 Urethral discharge   Sexual History                               Received anal sex
 Anal discharge        Time since last sex                        Sexual Contact
 Anal lesion           Number of partners in prior month           Male
 Genital rash          Number of new partners prior month          Female
 Genital Itch          Number of partners in prior 4 months        Sexual orientation
Past STIs              Number of new partners in prior 4 months    Transgender
 Gonorrhea             Number of lifetime partners                 Transexual
 Chlamydia            Other Risks                                 Contraception
 HSV                   Injection drug use (IDU)                    None
 Genital warts         Sexual contact with prostitute              Condom and percent use
 Scabies               Acting as a prostitute                      Condom rupture/slip off
 Crabs                 Sexual contact with IDU
 Scabies               Sexual contact HIV positive
 Trichomonas           Sexual contact HCV positive
 Epidiymitis           Blood transfusion and year
 Syphilis
Logistic
Regression
Web Figure 1.


                                0.012



                                                         High
                                0.010

                                                                   High Moderate
                                0.008
 Probability of HIV Infection




                                0.006                                   Moderate


                                0.004




                                0.002
                                                                                Low

                                0.000




                                        0   20   40                60      80         100

                                                      Age, years
Variable                               β          (95% CI)‡        Score§
Age
   <22 or >60 years                   Ref             -               0
   22-25 or 55-60 years               0.43      (0.14 – 0.72)        +4
   26-32 or 47-54 years               1.01      (0.65 – 1.35)        +10
   33-46 years                        1.09      (0.77 – 1.39)        +11
Sex
   Female                             Ref             -               0
   Male                               2.67      (2.19 – 3.14)        +27
Race/Ethnicity
   Black                              0.84      (0.64 – 1.04)        +8
   Hispanic                           0.26      (0.03 – 0.49)        +3
   Other*                              0†             -               0
   White                              Ref             -               0
Sexual Behaviors
   Sex with Male                       2.10     (1.69 – 2.53)        +21
   Sex with Female in Past Year       -0.60    (-0.18 – -1.00)        -6
   Sex with HIV-Infected Partner       0.55     (0.33 – 0.77)        +6
Type of Sexual Contact
   Vaginal Intercourse                -0.57     (-0.16 – -0.99)      -6
   Insertive Anal Intercourse         -0.26     (-0.02 – -0.51)      -3
   Receptive Anal Intercourse          0.85      (0.59 – 1.12)       +9
   Oral Intercourse                   -0.37     (-0.09 – -0.64)      -4
Other Behaviors
   Injection Drug Use                  0.71      (0.43 – 1.01)       +7
   Prostitution in Past Year           0.70      (0.14 – 1.31)       +7
   Past HIV Test                      -0.48     (-0.29 – -0.68)      -5
Symptoms
   History of Syphilis                0.38      (0.00 – 0.83)        +4
   Rash                               0.53      (0.21 – 0.88)        +5
   Genital Discharge                  0.27      (0.10 – 0.45)        +3
*Represents American or Alaskan Native, Native Hawaiian, or non-Hawaiian
Area under the
                    Slope (β) of the       R2 of the linear
                                                                    receiver
                   linear regression       regression line
                                                                   operating
                       line for the      for the calibration
                                                                 characteristics
                     calibration plot            plot
Model*                                                               curve
Model 14                  0.82                   0.88                  0.86
Model 15                  0.71                   0.67                  0.85
Model 16                  0.78                   0.91                  0.86
Model 17                  0.93                   0.78                  0.86
Model 18                  0.84                   0.87                  0.86
Model 19                  1.05                   0.78                  0.85
Model 20                  0.95                   0.94                  0.85
Model 21                  0.79                   0.96                  0.85
Model 22†                 1.02                   0.91                  0.85
Model 23                  0.91                   0.69                  0.85
Model 24                  1.42                   0.82                  0.85
Model 25                  1.41                   0.90                  0.85
Calibration plots were graphed using the predicted and observed prevalence of
  HIV infection in 10 distinct groups categorized using deciles of the predicted
  prevalence.
*See text for descriptions of variables included in each model.
†
  Model 22 was chosen as the final model and includes: age, sex, race/ethnicity,
  sex with a male, vaginal intercourse, receptive anal intercourse, injection drug
  use, and past HIV test.
Denver HIV Risk Score
 Variable                              β (95% CI)             Score
 Age
  <22 or >60 years                   ref -                        0
  22-25 or 55-60 years               0.4 (0.3 – 0.8)             +4
  26-32 or 47-54 years               1.0 (0.7 – 1.3)           +10
  33-46 years                        1.2 (0.9 – 1.5)           +12
 Gender
  Female                             ref -                        0
  Male                               2.1 (1.8 – 2.4)           +21
 Race/Ethnicity
  Black                              0.9 (0.7 – 1.1)             +9
  Hispanic                           0.3 (0.1 – 0.5)             +3
  Other*                            -0.1 (-0.3 – 0.1)             0
  White                              ref -                        0
 Sexual Practices
  Sex with a male                    2.2 (2.0 – 2.5)           +22
  Vaginal intercourse               -1.0 (-0.8 – -1.2)          -10
  Receptive anal intercourse         0.8 (0.6 – 1.0)             +8
 Other Risks
  Injection drug use                 0.9 (0.7 – 1.1)             +9
  Past HIV test                     -0.4 (-0.2 – -0.6)           -4
*Represents American or Alaskan Native, Native Hawaiian, or non-
 Hawaiian Pacific Islander.

                                 Haukoos et al. Am J Epidemiol 2012;175:838-846.
7

                         Derivation
                    6    Validation


HIV Prevalence, %   5


                    4
                                                                    3.59%
                    3


                    2
                                                          1.59%
                    1
                                                0.99%

                    0                 0.41%
                          0.31%

                        <20     20 - 29   30 - 39   40 - 49   >50
                                                              _

                                      HIV Risk Score
A)
                                  18
                                               Derivation
                                  16           Validation


                                  14
     Observed HIV Prevalence, %
                                  12


                                  10


                                  8


                                  6


                                  4


                                  2


                                  0
                                       0   2       4        6   8     10    12       14   16   18

                                                       Predicted HIV Prevalence, %
B)
                            Derivation
                 100
                           Derivation
                           Validation


Sensitivity, %    80




                  60

                                                            Validation

                  40



                                              Derivation AUC = 0.85
                  20                          (95% CI: 0.83-0.88)
                                              Validation AUC = 0.75
                                              (95% CI: 0.70-0.78)
                   0
                       0          20     40          60       80         100

                                         1-Specificity, %
Classification
    Tree
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection
Denver HIV Decision Tree

                       Yes   0/1,229
Age <16 or >61 years
                             (0%, 95% CI: 0% - 0.2%)


                       Yes   170/83,444
MSW or Female
                             (0.2%, 95% CI: 0.2% - 0.2%)


                       Yes   334/7,962
MSM or MSB
                             (4.2%, 95% CI: 3.8% - 4.7%)
Future Directions
External validation of the Denver HIV Decision Tree
Comparative clinical and cost effectiveness of the
different HIV screening approaches
Conclusions
Multivariable analyses have become increasingly
important in clinical research

Parametric regression techniques have historically been
the root for analyzing multivariable problems

Specific public health-related research questions lend
themselves to both traditional and non-traditional
multivariable techniques
Applied Multivariable
  Modeling in Public Health
Use of CART® and Logistic Regression to
     Help Diagnose HIV Infection

                 Jason S. Haukoos, MD, MSc
          Associate Professor & Director of Research
             Department of Emergency Medicine
                Denver Health Medical Center
          University of Colorado School of Medicine
                Department of Epidemiology
              Colorado School of Public Health
                       Denver, Colorado

      Salford Analytics and Data Mining Conference 2012
                         May 25, 2012
Ad

More Related Content

Viewers also liked (9)

Predictive Modeling in Insurance in the context of (possibly) big data
Predictive Modeling in Insurance in the context of (possibly) big dataPredictive Modeling in Insurance in the context of (possibly) big data
Predictive Modeling in Insurance in the context of (possibly) big data
Arthur Charpentier
 
Decision tree and random forest
Decision tree and random forestDecision tree and random forest
Decision tree and random forest
Lippo Group Digital
 
Logistic regression
Logistic regressionLogistic regression
Logistic regression
Khaled Abd Elaziz
 
Logistic management
Logistic managementLogistic management
Logistic management
jimcyvarghese
 
Bayesian Belief Networks for dummies
Bayesian Belief Networks for dummiesBayesian Belief Networks for dummies
Bayesian Belief Networks for dummies
Gilad Barkan
 
Logistic regression
Logistic regressionLogistic regression
Logistic regression
saba khan
 
Using CART For Beginners with A Teclo Example Dataset
Using CART For Beginners with A Teclo Example DatasetUsing CART For Beginners with A Teclo Example Dataset
Using CART For Beginners with A Teclo Example Dataset
Salford Systems
 
LinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-PresentedLinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-Presented
SlideShare
 
Slideshare ppt
Slideshare pptSlideshare ppt
Slideshare ppt
Mandy Suzanne
 
Predictive Modeling in Insurance in the context of (possibly) big data
Predictive Modeling in Insurance in the context of (possibly) big dataPredictive Modeling in Insurance in the context of (possibly) big data
Predictive Modeling in Insurance in the context of (possibly) big data
Arthur Charpentier
 
Bayesian Belief Networks for dummies
Bayesian Belief Networks for dummiesBayesian Belief Networks for dummies
Bayesian Belief Networks for dummies
Gilad Barkan
 
Logistic regression
Logistic regressionLogistic regression
Logistic regression
saba khan
 
Using CART For Beginners with A Teclo Example Dataset
Using CART For Beginners with A Teclo Example DatasetUsing CART For Beginners with A Teclo Example Dataset
Using CART For Beginners with A Teclo Example Dataset
Salford Systems
 
LinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-PresentedLinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-Presented
SlideShare
 

Similar to Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection (20)

22 patricia millernov1
22 patricia millernov122 patricia millernov1
22 patricia millernov1
CBRC
 
Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...
CDC NPIN
 
Fear Less Live More campaign
Fear Less Live More campaignFear Less Live More campaign
Fear Less Live More campaign
Australian Federation of AIDS Organisations
 
Do gay men who get infected with HIV have a history of regular HIV testing?
Do gay men who get infected with HIV have a history of regular HIV testing?Do gay men who get infected with HIV have a history of regular HIV testing?
Do gay men who get infected with HIV have a history of regular HIV testing?
Australian Federation of AIDS Organisations
 
HIV AIDS Presentation 2014
HIV AIDS Presentation 2014 HIV AIDS Presentation 2014
HIV AIDS Presentation 2014
AIDS Programs South Saskatchewan
 
HIV in Tubercular children
HIV in Tubercular childrenHIV in Tubercular children
HIV in Tubercular children
Virendra Hindustani
 
Wepdc204
Wepdc204Wepdc204
Wepdc204
Mohamed Rafique
 
Wepdc204
Wepdc204Wepdc204
Wepdc204
Mohamed Rafique
 
Community Testing: M Clinic Reflections
Community Testing: M Clinic ReflectionsCommunity Testing: M Clinic Reflections
Community Testing: M Clinic Reflections
Australian Federation of AIDS Organisations
 
Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...
Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...
Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...
Paul Pietquin
 
3 tue 0800 ross tue universal testing atlanta 2011
3 tue 0800 ross tue universal testing atlanta 20113 tue 0800 ross tue universal testing atlanta 2011
3 tue 0800 ross tue universal testing atlanta 2011
CDC NPIN
 
Faraway, so close: HIV-related stigma among gay and other men who have sex wi...
Faraway, so close: HIV-related stigma among gay and other men who have sex wi...Faraway, so close: HIV-related stigma among gay and other men who have sex wi...
Faraway, so close: HIV-related stigma among gay and other men who have sex wi...
Australian Federation of AIDS Organisations
 
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
Jacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor RiskJacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor Risk
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
incucai_isodp
 
Know Aids No Aids
Know Aids No AidsKnow Aids No Aids
Know Aids No Aids
Abhishek Shah
 
How are HIV-negative and HIV-positive gay men changing over time and what doe...
How are HIV-negative and HIV-positive gay men changing over time and what doe...How are HIV-negative and HIV-positive gay men changing over time and what doe...
How are HIV-negative and HIV-positive gay men changing over time and what doe...
Australian Federation of AIDS Organisations
 
The impact of gender inequity and violence on HIV prevention with vulnerable ...
The impact of gender inequity and violence on HIV prevention with vulnerable ...The impact of gender inequity and violence on HIV prevention with vulnerable ...
The impact of gender inequity and violence on HIV prevention with vulnerable ...
HopkinsCFAR
 
Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...
Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...
Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...
CDC NPIN
 
Mostly heterosexual
Mostly heterosexualMostly heterosexual
Mostly heterosexual
Zhana Vrangalova
 
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...
CDC NPIN
 
jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...
jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...
jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...
Partnerships in Health
 
22 patricia millernov1
22 patricia millernov122 patricia millernov1
22 patricia millernov1
CBRC
 
Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...
CDC NPIN
 
Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...
Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...
Examples from HIV Prevention and Treatment: HIV Prevention among Men Who Have...
Paul Pietquin
 
3 tue 0800 ross tue universal testing atlanta 2011
3 tue 0800 ross tue universal testing atlanta 20113 tue 0800 ross tue universal testing atlanta 2011
3 tue 0800 ross tue universal testing atlanta 2011
CDC NPIN
 
Faraway, so close: HIV-related stigma among gay and other men who have sex wi...
Faraway, so close: HIV-related stigma among gay and other men who have sex wi...Faraway, so close: HIV-related stigma among gay and other men who have sex wi...
Faraway, so close: HIV-related stigma among gay and other men who have sex wi...
Australian Federation of AIDS Organisations
 
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
Jacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor RiskJacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor Risk
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
incucai_isodp
 
How are HIV-negative and HIV-positive gay men changing over time and what doe...
How are HIV-negative and HIV-positive gay men changing over time and what doe...How are HIV-negative and HIV-positive gay men changing over time and what doe...
How are HIV-negative and HIV-positive gay men changing over time and what doe...
Australian Federation of AIDS Organisations
 
The impact of gender inequity and violence on HIV prevention with vulnerable ...
The impact of gender inequity and violence on HIV prevention with vulnerable ...The impact of gender inequity and violence on HIV prevention with vulnerable ...
The impact of gender inequity and violence on HIV prevention with vulnerable ...
HopkinsCFAR
 
Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...
Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...
Impact of Chronic HCV Co-infection on HIV Clinical Outcomes in the District o...
CDC NPIN
 
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health S...
CDC NPIN
 
jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...
jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...
jovan ranin - overview of HCV and HBV co-infections in patients with HIV in S...
Partnerships in Health
 
Ad

More from Salford Systems (20)

Datascience101presentation4
Datascience101presentation4Datascience101presentation4
Datascience101presentation4
Salford Systems
 
Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...
Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...
Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...
Salford Systems
 
The Do's and Don'ts of Data Mining
The Do's and Don'ts of Data MiningThe Do's and Don'ts of Data Mining
The Do's and Don'ts of Data Mining
Salford Systems
 
Introduction to Random Forests by Dr. Adele Cutler
Introduction to Random Forests by Dr. Adele CutlerIntroduction to Random Forests by Dr. Adele Cutler
Introduction to Random Forests by Dr. Adele Cutler
Salford Systems
 
9 Data Mining Challenges From Data Scientists Like You
9 Data Mining Challenges From Data Scientists Like You9 Data Mining Challenges From Data Scientists Like You
9 Data Mining Challenges From Data Scientists Like You
Salford Systems
 
Statistically Significant Quotes To Remember
Statistically Significant Quotes To RememberStatistically Significant Quotes To Remember
Statistically Significant Quotes To Remember
Salford Systems
 
CART Classification and Regression Trees Experienced User Guide
CART Classification and Regression Trees Experienced User GuideCART Classification and Regression Trees Experienced User Guide
CART Classification and Regression Trees Experienced User Guide
Salford Systems
 
Evolution of regression ols to gps to mars
Evolution of regression   ols to gps to marsEvolution of regression   ols to gps to mars
Evolution of regression ols to gps to mars
Salford Systems
 
Data Mining for Higher Education
Data Mining for Higher EducationData Mining for Higher Education
Data Mining for Higher Education
Salford Systems
 
Comparison of statistical methods commonly used in predictive modeling
Comparison of statistical methods commonly used in predictive modelingComparison of statistical methods commonly used in predictive modeling
Comparison of statistical methods commonly used in predictive modeling
Salford Systems
 
Molecular data mining tool advances in hiv
Molecular data mining tool  advances in hivMolecular data mining tool  advances in hiv
Molecular data mining tool advances in hiv
Salford Systems
 
TreeNet Tree Ensembles & CART Decision Trees: A Winning Combination
TreeNet Tree Ensembles & CART Decision Trees:  A Winning CombinationTreeNet Tree Ensembles & CART Decision Trees:  A Winning Combination
TreeNet Tree Ensembles & CART Decision Trees: A Winning Combination
Salford Systems
 
SPM v7.0 Feature Matrix
SPM v7.0 Feature MatrixSPM v7.0 Feature Matrix
SPM v7.0 Feature Matrix
Salford Systems
 
SPM User's Guide: Introducing MARS
SPM User's Guide: Introducing MARSSPM User's Guide: Introducing MARS
SPM User's Guide: Introducing MARS
Salford Systems
 
Hybrid cart logit model 1998
Hybrid cart logit model 1998Hybrid cart logit model 1998
Hybrid cart logit model 1998
Salford Systems
 
Session Logs Tutorial for SPM
Session Logs Tutorial for SPMSession Logs Tutorial for SPM
Session Logs Tutorial for SPM
Salford Systems
 
Some of the new features in SPM 7
Some of the new features in SPM 7Some of the new features in SPM 7
Some of the new features in SPM 7
Salford Systems
 
TreeNet Overview - Updated October 2012
TreeNet Overview  - Updated October 2012TreeNet Overview  - Updated October 2012
TreeNet Overview - Updated October 2012
Salford Systems
 
TreeNet Tree Ensembles and CART Decision Trees: A Winning Combination
TreeNet Tree Ensembles and CART  Decision Trees:  A Winning CombinationTreeNet Tree Ensembles and CART  Decision Trees:  A Winning Combination
TreeNet Tree Ensembles and CART Decision Trees: A Winning Combination
Salford Systems
 
Text mining tutorial
Text mining tutorialText mining tutorial
Text mining tutorial
Salford Systems
 
Datascience101presentation4
Datascience101presentation4Datascience101presentation4
Datascience101presentation4
Salford Systems
 
Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...
Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...
Improved Predictions in Structure Based Drug Design Using Cart and Bayesian M...
Salford Systems
 
The Do's and Don'ts of Data Mining
The Do's and Don'ts of Data MiningThe Do's and Don'ts of Data Mining
The Do's and Don'ts of Data Mining
Salford Systems
 
Introduction to Random Forests by Dr. Adele Cutler
Introduction to Random Forests by Dr. Adele CutlerIntroduction to Random Forests by Dr. Adele Cutler
Introduction to Random Forests by Dr. Adele Cutler
Salford Systems
 
9 Data Mining Challenges From Data Scientists Like You
9 Data Mining Challenges From Data Scientists Like You9 Data Mining Challenges From Data Scientists Like You
9 Data Mining Challenges From Data Scientists Like You
Salford Systems
 
Statistically Significant Quotes To Remember
Statistically Significant Quotes To RememberStatistically Significant Quotes To Remember
Statistically Significant Quotes To Remember
Salford Systems
 
CART Classification and Regression Trees Experienced User Guide
CART Classification and Regression Trees Experienced User GuideCART Classification and Regression Trees Experienced User Guide
CART Classification and Regression Trees Experienced User Guide
Salford Systems
 
Evolution of regression ols to gps to mars
Evolution of regression   ols to gps to marsEvolution of regression   ols to gps to mars
Evolution of regression ols to gps to mars
Salford Systems
 
Data Mining for Higher Education
Data Mining for Higher EducationData Mining for Higher Education
Data Mining for Higher Education
Salford Systems
 
Comparison of statistical methods commonly used in predictive modeling
Comparison of statistical methods commonly used in predictive modelingComparison of statistical methods commonly used in predictive modeling
Comparison of statistical methods commonly used in predictive modeling
Salford Systems
 
Molecular data mining tool advances in hiv
Molecular data mining tool  advances in hivMolecular data mining tool  advances in hiv
Molecular data mining tool advances in hiv
Salford Systems
 
TreeNet Tree Ensembles & CART Decision Trees: A Winning Combination
TreeNet Tree Ensembles & CART Decision Trees:  A Winning CombinationTreeNet Tree Ensembles & CART Decision Trees:  A Winning Combination
TreeNet Tree Ensembles & CART Decision Trees: A Winning Combination
Salford Systems
 
SPM User's Guide: Introducing MARS
SPM User's Guide: Introducing MARSSPM User's Guide: Introducing MARS
SPM User's Guide: Introducing MARS
Salford Systems
 
Hybrid cart logit model 1998
Hybrid cart logit model 1998Hybrid cart logit model 1998
Hybrid cart logit model 1998
Salford Systems
 
Session Logs Tutorial for SPM
Session Logs Tutorial for SPMSession Logs Tutorial for SPM
Session Logs Tutorial for SPM
Salford Systems
 
Some of the new features in SPM 7
Some of the new features in SPM 7Some of the new features in SPM 7
Some of the new features in SPM 7
Salford Systems
 
TreeNet Overview - Updated October 2012
TreeNet Overview  - Updated October 2012TreeNet Overview  - Updated October 2012
TreeNet Overview - Updated October 2012
Salford Systems
 
TreeNet Tree Ensembles and CART Decision Trees: A Winning Combination
TreeNet Tree Ensembles and CART  Decision Trees:  A Winning CombinationTreeNet Tree Ensembles and CART  Decision Trees:  A Winning Combination
TreeNet Tree Ensembles and CART Decision Trees: A Winning Combination
Salford Systems
 
Ad

Recently uploaded (20)

Bala Samvardhana (Growth and Development)_010548.pdf
Bala Samvardhana (Growth and Development)_010548.pdfBala Samvardhana (Growth and Development)_010548.pdf
Bala Samvardhana (Growth and Development)_010548.pdf
aditijogal
 
451 Multiple Choice Questions (MCQS) .docx
451 Multiple Choice Questions (MCQS) .docx451 Multiple Choice Questions (MCQS) .docx
451 Multiple Choice Questions (MCQS) .docx
Riyad Banayot
 
tmjdisorder and its managementnnnnn.pptx
tmjdisorder and its managementnnnnn.pptxtmjdisorder and its managementnnnnn.pptx
tmjdisorder and its managementnnnnn.pptx
ArifKhan101342
 
Environmental Health policy, by Dechasa Adare (Ass.Professor))
Environmental Health  policy, by Dechasa Adare (Ass.Professor))Environmental Health  policy, by Dechasa Adare (Ass.Professor))
Environmental Health policy, by Dechasa Adare (Ass.Professor))
DechasaAdare
 
Formulation of herbal hand sanitizer using various herbal extract.pptx
Formulation of herbal hand sanitizer using various herbal extract.pptxFormulation of herbal hand sanitizer using various herbal extract.pptx
Formulation of herbal hand sanitizer using various herbal extract.pptx
DHANASHREE KOLHEKAR
 
111 Disorders of blood vessels 2022.pptx
111 Disorders of blood vessels 2022.pptx111 Disorders of blood vessels 2022.pptx
111 Disorders of blood vessels 2022.pptx
SimaJabri
 
COMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdf
COMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdfCOMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdf
COMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdf
Dr. Ravikiran H M Gowda
 
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...
RheannaRandazzo
 
222 The pathology of the heart 2022.pptx
222 The pathology of the heart 2022.pptx222 The pathology of the heart 2022.pptx
222 The pathology of the heart 2022.pptx
SimaJabri
 
Earn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood Today
Earn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood TodayEarn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood Today
Earn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood Today
Daniel P
 
FOR DRUG DISCOVERY, BIOMARKER DEVELOPMENT AND ADVANCED R&D LANDSCAPE OVERV...
FOR DRUG DISCOVERY,  BIOMARKER DEVELOPMENT  AND ADVANCED R&D LANDSCAPE  OVERV...FOR DRUG DISCOVERY,  BIOMARKER DEVELOPMENT  AND ADVANCED R&D LANDSCAPE  OVERV...
FOR DRUG DISCOVERY, BIOMARKER DEVELOPMENT AND ADVANCED R&D LANDSCAPE OVERV...
smegantara1
 
Courtney - Slides_SAL 12 Step Conference.pdf
Courtney - Slides_SAL 12 Step Conference.pdfCourtney - Slides_SAL 12 Step Conference.pdf
Courtney - Slides_SAL 12 Step Conference.pdf
websupport11
 
Biologic Therapy for CRSwNP: Exploring the Advanced Practice Provider’s Role ...
Biologic Therapy for CRSwNP: Exploring the Advanced Practice Provider’s Role ...Biologic Therapy for CRSwNP: Exploring the Advanced Practice Provider’s Role ...
Biologic Therapy for CRSwNP: Exploring the Advanced Practice Provider’s Role ...
PVI, PeerView Institute for Medical Education
 
Jon Taylor - Slides_SAL 12 Step Conference.pdf
Jon Taylor - Slides_SAL 12 Step Conference.pdfJon Taylor - Slides_SAL 12 Step Conference.pdf
Jon Taylor - Slides_SAL 12 Step Conference.pdf
websupport11
 
Multiple Choice Questions (MCQS) Basic and Clinical Science Course.doc
Multiple Choice Questions (MCQS)  Basic and Clinical Science Course.docMultiple Choice Questions (MCQS)  Basic and Clinical Science Course.doc
Multiple Choice Questions (MCQS) Basic and Clinical Science Course.doc
Riyad Banayot
 
PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...
PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...
PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...
Dr Rashmi Sood
 
SE2024.pptx status epilepticus management
SE2024.pptx status epilepticus managementSE2024.pptx status epilepticus management
SE2024.pptx status epilepticus management
Balqees Majali
 
Overview of Liver Immune Test by Sajjad Fadhil K. Abbas
Overview of Liver Immune Test by Sajjad Fadhil K. AbbasOverview of Liver Immune Test by Sajjad Fadhil K. Abbas
Overview of Liver Immune Test by Sajjad Fadhil K. Abbas
Sajjad Fadhil K. Abbas
 
neuroanatomical terms and organization of central nervous system
neuroanatomical terms and organization of central nervous systemneuroanatomical terms and organization of central nervous system
neuroanatomical terms and organization of central nervous system
Abdelraouf Abheiri
 
Dialysis and care of person with dialysis .pptx
Dialysis and care of person with dialysis .pptxDialysis and care of person with dialysis .pptx
Dialysis and care of person with dialysis .pptx
Rishika Rawat
 
Bala Samvardhana (Growth and Development)_010548.pdf
Bala Samvardhana (Growth and Development)_010548.pdfBala Samvardhana (Growth and Development)_010548.pdf
Bala Samvardhana (Growth and Development)_010548.pdf
aditijogal
 
451 Multiple Choice Questions (MCQS) .docx
451 Multiple Choice Questions (MCQS) .docx451 Multiple Choice Questions (MCQS) .docx
451 Multiple Choice Questions (MCQS) .docx
Riyad Banayot
 
tmjdisorder and its managementnnnnn.pptx
tmjdisorder and its managementnnnnn.pptxtmjdisorder and its managementnnnnn.pptx
tmjdisorder and its managementnnnnn.pptx
ArifKhan101342
 
Environmental Health policy, by Dechasa Adare (Ass.Professor))
Environmental Health  policy, by Dechasa Adare (Ass.Professor))Environmental Health  policy, by Dechasa Adare (Ass.Professor))
Environmental Health policy, by Dechasa Adare (Ass.Professor))
DechasaAdare
 
Formulation of herbal hand sanitizer using various herbal extract.pptx
Formulation of herbal hand sanitizer using various herbal extract.pptxFormulation of herbal hand sanitizer using various herbal extract.pptx
Formulation of herbal hand sanitizer using various herbal extract.pptx
DHANASHREE KOLHEKAR
 
111 Disorders of blood vessels 2022.pptx
111 Disorders of blood vessels 2022.pptx111 Disorders of blood vessels 2022.pptx
111 Disorders of blood vessels 2022.pptx
SimaJabri
 
COMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdf
COMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdfCOMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdf
COMPILATION OF DIFFERENCES IN ANESTHESIA 2nd edition.pdf
Dr. Ravikiran H M Gowda
 
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinica...
RheannaRandazzo
 
222 The pathology of the heart 2022.pptx
222 The pathology of the heart 2022.pptx222 The pathology of the heart 2022.pptx
222 The pathology of the heart 2022.pptx
SimaJabri
 
Earn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood Today
Earn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood TodayEarn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood Today
Earn from Home, Promote Wellness, Get Paid Weekly – Discover LiveGood Today
Daniel P
 
FOR DRUG DISCOVERY, BIOMARKER DEVELOPMENT AND ADVANCED R&D LANDSCAPE OVERV...
FOR DRUG DISCOVERY,  BIOMARKER DEVELOPMENT  AND ADVANCED R&D LANDSCAPE  OVERV...FOR DRUG DISCOVERY,  BIOMARKER DEVELOPMENT  AND ADVANCED R&D LANDSCAPE  OVERV...
FOR DRUG DISCOVERY, BIOMARKER DEVELOPMENT AND ADVANCED R&D LANDSCAPE OVERV...
smegantara1
 
Courtney - Slides_SAL 12 Step Conference.pdf
Courtney - Slides_SAL 12 Step Conference.pdfCourtney - Slides_SAL 12 Step Conference.pdf
Courtney - Slides_SAL 12 Step Conference.pdf
websupport11
 
Jon Taylor - Slides_SAL 12 Step Conference.pdf
Jon Taylor - Slides_SAL 12 Step Conference.pdfJon Taylor - Slides_SAL 12 Step Conference.pdf
Jon Taylor - Slides_SAL 12 Step Conference.pdf
websupport11
 
Multiple Choice Questions (MCQS) Basic and Clinical Science Course.doc
Multiple Choice Questions (MCQS)  Basic and Clinical Science Course.docMultiple Choice Questions (MCQS)  Basic and Clinical Science Course.doc
Multiple Choice Questions (MCQS) Basic and Clinical Science Course.doc
Riyad Banayot
 
PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...
PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...
PATIENT BLOOD MANAGEMENT IMPLEMENTATION BUNDLES A POWER POINT PRESENTATION BA...
Dr Rashmi Sood
 
SE2024.pptx status epilepticus management
SE2024.pptx status epilepticus managementSE2024.pptx status epilepticus management
SE2024.pptx status epilepticus management
Balqees Majali
 
Overview of Liver Immune Test by Sajjad Fadhil K. Abbas
Overview of Liver Immune Test by Sajjad Fadhil K. AbbasOverview of Liver Immune Test by Sajjad Fadhil K. Abbas
Overview of Liver Immune Test by Sajjad Fadhil K. Abbas
Sajjad Fadhil K. Abbas
 
neuroanatomical terms and organization of central nervous system
neuroanatomical terms and organization of central nervous systemneuroanatomical terms and organization of central nervous system
neuroanatomical terms and organization of central nervous system
Abdelraouf Abheiri
 
Dialysis and care of person with dialysis .pptx
Dialysis and care of person with dialysis .pptxDialysis and care of person with dialysis .pptx
Dialysis and care of person with dialysis .pptx
Rishika Rawat
 

Applied Multivariable Modeling in Public Health: Use of CART and Logistic Regression to Help Diagnose HIV Infection

  • 1. Applied Multivariable Modeling in Public Health Use of CART® and Logistic Regression to Help Diagnose HIV Infection Jason S. Haukoos, MD, MSc Associate Professor & Director of Research Department of Emergency Medicine Denver Health Medical Center University of Colorado School of Medicine Department of Epidemiology Colorado School of Public Health Denver, Colorado Salford Analytics and Data Mining Conference 2012 May 25, 2012
  • 2. Supported by an Independent Scientist Award (K02 HS017526) from the Agency for Healthcare Research and Quality
  • 4. Awareness in the United States Number with HIV infection 1,200,000 Number unaware of HIV infection 250,000 Annual new infections 56,000
  • 6. HIV Epidemic in the U.S. The numbers of people infected with HIV is growing fastest among Racial and ethnic minorities Social and economically disadvantaged These are the same groups that are Under- or uninsured Do not have primary medical care Commonly seek medical care in emergency departments
  • 8. Earlier Diagnosis of HIV Infection Benefits both Patient and Public Benefits for the Patient Timely linkage to care Reduced morbidity and mortality due to HAART Reduced at-risk behavior Benefits for the Public Earlier treatment, decreased viral load, decreased transmission Reduced unscheduled medical care and length of inpatient hospitalizations
  • 10. Strategies for Uncovering HIV Figure 1. Conceptual model for performing HIV testing in emergency departments. Nontargeted HIV No HIV Screening Testing (“Routine Screening”) Diagnostic Testing Traditional Targeted Enhanced Targeted (Signs or Symptoms) Screening Screening Selection of Selection of Individuals Populations Referral for outpatient Operational Considerations for All Testing Models HIV testing Opt-in versus Opt-out Consent Education versus Counseling Rapid versus Conventional Assay Point-of-Care Testing versus Laboratory-based Testing Result Notification, Reporting, and Linkage of Positives Native versus External Resources Rothman et al. Acad Emerg Med 2007;14:653-657.
  • 12. Haukoos. Arch Intern Med 2012;172:20-22.
  • 13. Objective To systematically evaluate a large number of characteristics to derive a clinically meaningful and valid prediction tool to accurately categorize patients into risk groups for undiagnosed HIV infection
  • 14. Derivation Methods Denver Metro Health STD Clinic, Denver, CO 10,000 annual visits & 0.5% HIV prevalence Consecutive patients from 1/1/1996 – 12/31/2008
  • 18. Candidate Variables Demographics Hepatitis B Sexual Practices Age Hepatitis C Vaginal sex Sex Previous HIV Testing Given oral sex Race/ethnicity Ever tested Received oral sex Symptoms Last tested Given anal sex Urethral discharge Sexual History Received anal sex Anal discharge Time since last sex Sexual Contact Anal lesion Number of partners in prior month Male Genital rash Number of new partners prior month Female Genital Itch Number of partners in prior 4 months Sexual orientation Past STIs Number of new partners in prior 4 months Transgender Gonorrhea Number of lifetime partners Transexual Chlamydia Other Risks Contraception HSV Injection drug use (IDU) None Genital warts Sexual contact with prostitute Condom and percent use Scabies Acting as a prostitute Condom rupture/slip off Crabs Sexual contact with IDU Scabies Sexual contact HIV positive Trichomonas Sexual contact HCV positive Epidiymitis Blood transfusion and year Syphilis
  • 20. Web Figure 1. 0.012 High 0.010 High Moderate 0.008 Probability of HIV Infection 0.006 Moderate 0.004 0.002 Low 0.000 0 20 40 60 80 100 Age, years
  • 21. Variable β (95% CI)‡ Score§ Age <22 or >60 years Ref - 0 22-25 or 55-60 years 0.43 (0.14 – 0.72) +4 26-32 or 47-54 years 1.01 (0.65 – 1.35) +10 33-46 years 1.09 (0.77 – 1.39) +11 Sex Female Ref - 0 Male 2.67 (2.19 – 3.14) +27 Race/Ethnicity Black 0.84 (0.64 – 1.04) +8 Hispanic 0.26 (0.03 – 0.49) +3 Other* 0† - 0 White Ref - 0 Sexual Behaviors Sex with Male 2.10 (1.69 – 2.53) +21 Sex with Female in Past Year -0.60 (-0.18 – -1.00) -6 Sex with HIV-Infected Partner 0.55 (0.33 – 0.77) +6 Type of Sexual Contact Vaginal Intercourse -0.57 (-0.16 – -0.99) -6 Insertive Anal Intercourse -0.26 (-0.02 – -0.51) -3 Receptive Anal Intercourse 0.85 (0.59 – 1.12) +9 Oral Intercourse -0.37 (-0.09 – -0.64) -4 Other Behaviors Injection Drug Use 0.71 (0.43 – 1.01) +7 Prostitution in Past Year 0.70 (0.14 – 1.31) +7 Past HIV Test -0.48 (-0.29 – -0.68) -5 Symptoms History of Syphilis 0.38 (0.00 – 0.83) +4 Rash 0.53 (0.21 – 0.88) +5 Genital Discharge 0.27 (0.10 – 0.45) +3 *Represents American or Alaskan Native, Native Hawaiian, or non-Hawaiian
  • 22. Area under the Slope (β) of the R2 of the linear receiver linear regression regression line operating line for the for the calibration characteristics calibration plot plot Model* curve Model 14 0.82 0.88 0.86 Model 15 0.71 0.67 0.85 Model 16 0.78 0.91 0.86 Model 17 0.93 0.78 0.86 Model 18 0.84 0.87 0.86 Model 19 1.05 0.78 0.85 Model 20 0.95 0.94 0.85 Model 21 0.79 0.96 0.85 Model 22† 1.02 0.91 0.85 Model 23 0.91 0.69 0.85 Model 24 1.42 0.82 0.85 Model 25 1.41 0.90 0.85 Calibration plots were graphed using the predicted and observed prevalence of HIV infection in 10 distinct groups categorized using deciles of the predicted prevalence. *See text for descriptions of variables included in each model. † Model 22 was chosen as the final model and includes: age, sex, race/ethnicity, sex with a male, vaginal intercourse, receptive anal intercourse, injection drug use, and past HIV test.
  • 23. Denver HIV Risk Score Variable β (95% CI) Score Age <22 or >60 years ref - 0 22-25 or 55-60 years 0.4 (0.3 – 0.8) +4 26-32 or 47-54 years 1.0 (0.7 – 1.3) +10 33-46 years 1.2 (0.9 – 1.5) +12 Gender Female ref - 0 Male 2.1 (1.8 – 2.4) +21 Race/Ethnicity Black 0.9 (0.7 – 1.1) +9 Hispanic 0.3 (0.1 – 0.5) +3 Other* -0.1 (-0.3 – 0.1) 0 White ref - 0 Sexual Practices Sex with a male 2.2 (2.0 – 2.5) +22 Vaginal intercourse -1.0 (-0.8 – -1.2) -10 Receptive anal intercourse 0.8 (0.6 – 1.0) +8 Other Risks Injection drug use 0.9 (0.7 – 1.1) +9 Past HIV test -0.4 (-0.2 – -0.6) -4 *Represents American or Alaskan Native, Native Hawaiian, or non- Hawaiian Pacific Islander. Haukoos et al. Am J Epidemiol 2012;175:838-846.
  • 24. 7 Derivation 6 Validation HIV Prevalence, % 5 4 3.59% 3 2 1.59% 1 0.99% 0 0.41% 0.31% <20 20 - 29 30 - 39 40 - 49 >50 _ HIV Risk Score
  • 25. A) 18 Derivation 16 Validation 14 Observed HIV Prevalence, % 12 10 8 6 4 2 0 0 2 4 6 8 10 12 14 16 18 Predicted HIV Prevalence, %
  • 26. B) Derivation 100 Derivation Validation Sensitivity, % 80 60 Validation 40 Derivation AUC = 0.85 20 (95% CI: 0.83-0.88) Validation AUC = 0.75 (95% CI: 0.70-0.78) 0 0 20 40 60 80 100 1-Specificity, %
  • 33. Denver HIV Decision Tree Yes 0/1,229 Age <16 or >61 years (0%, 95% CI: 0% - 0.2%) Yes 170/83,444 MSW or Female (0.2%, 95% CI: 0.2% - 0.2%) Yes 334/7,962 MSM or MSB (4.2%, 95% CI: 3.8% - 4.7%)
  • 34. Future Directions External validation of the Denver HIV Decision Tree Comparative clinical and cost effectiveness of the different HIV screening approaches
  • 35. Conclusions Multivariable analyses have become increasingly important in clinical research Parametric regression techniques have historically been the root for analyzing multivariable problems Specific public health-related research questions lend themselves to both traditional and non-traditional multivariable techniques
  • 36. Applied Multivariable Modeling in Public Health Use of CART® and Logistic Regression to Help Diagnose HIV Infection Jason S. Haukoos, MD, MSc Associate Professor & Director of Research Department of Emergency Medicine Denver Health Medical Center University of Colorado School of Medicine Department of Epidemiology Colorado School of Public Health Denver, Colorado Salford Analytics and Data Mining Conference 2012 May 25, 2012
  翻译: